About: Effects of discontinuation of digoxin versus continuation at low serum digoxin concentrations in chronic heart failure

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effects of discontinuation of digoxin versus continuation at low serum digoxin concentrations in chronic heart failure Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 06 June 2007

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2007 (ast) наукова стаття, опублікована в червні 2007 (uk) scientific article published on 06 June 2007 (en) مقالة علمية نشرت في 06 يونيو 2007 (ar)
publication date	wds:Q37199757-6B11CB47-14E6-41A0-909D-3715D7440CDF
publication date	2007-06-06 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37199757-F3FD5586-92FF-4E1E-A42F-612C082C2829
language of work or name	English
cites work	wds:Q37199757-0F913A5B-FBA9-4B57-B33B-B2016E7604BA wds:Q37199757-1C5D1F5B-75F7-4354-B38C-A4D34F76F637 wds:Q37199757-38E408D2-2F32-4F92-9A57-8B6754FDA756 wds:Q37199757-5477ECFD-5629-482B-9BB5-BB7D4DD57C2A wds:Q37199757-62E927A0-7080-435F-94A8-1E0F1C7E053F wds:Q37199757-8344C56F-E21A-48CF-BAB6-5A512E064AC7 wds:Q37199757-84B886EF-DCBC-402F-829C-7490FDEE7565 wds:Q37199757-8EF94726-F49E-4917-8A8D-0E8DE2DED125 wds:Q37199757-A5EA9622-082F-4182-B1B5-116771D6A0CC wds:Q37199757-AA687367-02CC-489F-89D1-B4745BA7B10D wds:Q37199757-BC104666-D53C-49EE-88C0-0464E8721543 wds:Q37199757-BE4D3327-5C5D-429E-A917-B0A6250308FB wds:Q37199757-C9CD972D-FDE7-4708-AA64-3E095B6A59FC wds:Q37199757-CC5CEB8A-3E3D-4F35-BE00-F523A50BA2B3 wds:Q37199757-CFD11285-0369-4788-8B63-667463D1D61E wds:Q37199757-DAFB1ACC-0B4E-4188-90F5-5C7086BBD1B8 wds:Q37199757-E34EE664-560F-4D3D-91DD-F62CFB2F31D8 wds:Q37199757-E937C666-1D18-4BC5-890B-1C180CBAD00D wds:Q37199757-E9E89D80-7E18-4938-B9C3-8B8515D27B4E wds:Q37199757-FE52199E-1C62-4753-AE59-4299E9F38AF7 wds:Q37199757-FF5B9A0A-3C78-488C-A92C-015BCB809332
cites work	Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...] The effect of digoxin on mortality and morbidity in patients with heart failure Determination of vital status at the end of the DIG trial. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial Association of serum digoxin concentration and outcomes in patients with heart failure Clinical benefits of low serum digoxin concentrations in heart failure Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings. Contemporary use of digoxin in the management of cardiovascular disorders Functional significance of Na- K-ATPase in the kidney: effects of ouabain inhibition Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study Effect of digoxin noncompliance on hospitalization and mortality in patients with heart failure in long-term therapy: a prospective cohort study Digitalis therapy for patients in clinical heart failure Patients with mild heart failure worsen during withdrawal from digoxin therapy Suppression of the renin-angiotensin system by intravenous digoxin in chronic congestive heart failure Effect of concomitant digoxin and carvedilol therapy on mortality and morbidity in patients with chronic heart failure Clinical predictors of worsening heart failure during withdrawal from digoxin therapy Digoxin. A neurohormonal modulator in heart failure?
author name string	wds:Q37199757-16A9609D-2732-4EB7-8EDB-A51A557FB6FB wds:Q37199757-29F112A9-418F-4409-8CA5-3C2F16B055A7 wds:Q37199757-5A53C119-168B-4873-84E4-A5AB47337EB9 wds:Q37199757-9169B25D-7E9B-4FF3-8D06-078CCD09E755 wds:Q37199757-CB149B15-BF99-435A-A1DA-7A830FCC31B4
author name string	James B Young Ali Ahmed Michael T Weaver William H Wehrmacher Giovanni Gambassi
rdfs:label	Effects of discontinuation of digoxin versus continuation at low serum digoxin concentrations in chronic heart failure (en) Effects of discontinuation of digoxin versus continuation at low serum digoxin concentrations in chronic heart failure (nl) Effects of discontinuation of digoxin versus continuation at low serum digoxin concentrations in chronic heart failure (ast)
skos:prefLabel	Effects of discontinuation of digoxin versus continuation at low serum digoxin concentrations in chronic heart failure (en) Effects of discontinuation of digoxin versus continuation at low serum digoxin concentrations in chronic heart failure (nl) Effects of discontinuation of digoxin versus continuation at low serum digoxin concentrations in chronic heart failure (ast)
name	Effects of discontinuation of digoxin versus continuation at low serum digoxin concentrations in chronic heart failure (en) Effects of discontinuation of digoxin versus continuation at low serum digoxin concentrations in chronic heart failure (nl) Effects of discontinuation of digoxin versus continuation at low serum digoxin concentrations in chronic heart failure (ast)
author	wds:Q37199757-D5BA8D24-CE99-4171-A122-7199EF4A84DA
author	Michael W. Rich
title	wds:Q37199757-F2BC8C14-AF22-4661-89E3-0B42CDF3BF7B
title	Effects of discontinuation of digoxin versus continuation at low serum digoxin concentrations in chronic heart failure (en)
page(s)	wds:Q37199757-6B315584-BB4E-4C1A-B2DA-EAF9ABB83EC9
page(s)	280-284
instance of	wds:Q37199757-4333D7A9-44A0-4B0D-BA7D-108071D1B1EA
instance of	scholarly article
main subject	wds:Q37199757-06187AAC-49CB-4203-9CEE-6CCC34BEA54A wds:Q37199757-2ADFE8FA-9838-4090-B7E7-44DFE490EAB1 wds:Q37199757-EC76C072-89F6-4292-BE3A-81E5F063B94A
main subject	heart failure wd:Q422222 chronic heart failure
PubMed ID	wds:Q37199757-87612D46-AFFB-4E57-AB44-EA3751F8ED69
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17631083
PubMed ID	17631083
published in	wds:Q37199757-5E615848-88CE-42AC-908E-A9417BC4F024

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software